Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen

被引:2
|
作者
Vokurka, Samuel [1 ]
Svoboda, Tomas [1 ]
Karas, Michal [1 ]
Koza, Vladimir [1 ]
Jindra, Pavel [1 ]
Kazakov, Dmitry [2 ]
Boudova, Ludmila [2 ]
机构
[1] Univ Hosp, Dept Hematooncol, Plzen 30460, Pilsen, Czech Republic
[2] Univ Hosp, Dept Pathol, Plzen 30460, Pilsen, Czech Republic
来源
MEDICAL SCIENCE MONITOR | 2011年 / 17卷 / 09期
关键词
graft-versus-host disease; melphalan; allogeneic transplantation; oral; BONE-MARROW; MELPHALAN; FLUDARABINE; RECIPIENTS;
D O I
10.12659/MSM.881933
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Oral graft-versus-host disease (GVHD) is a significant complication after allogeneic stem cell transplantation (SCT) and there is no consistent information about its characteristics in patients after reduced-intensity conditioning regimen FLU/MEL (fludarabine 12(1 mg/m(2) and melphalan 140mg/m(2)). Material/Methods: This was a single-centre prospective observational study of patients after allogeneic SCT with FLU/MEL conditioning performed during the period 1/2005-12/2007. Characteristics of oral GVHD were observed in 71 patients. The observation was discontinued due to death, donor lymphocyte infusion (DLI) or new chemotherapy administration. Results: In 10/2010, the median duration of the observation of the cohort of the patients was 13 (0.2-69) months, and 42 (35-69) months in the still-ongoing 20/71 (28%) patients. Oral acute GVHD had sporadic 7% incidence, whereas oral chronic GVHD was observed in 33% of patients and persisted with median duration of 188 (11-665) days. Clinical and histopathological features were similar in both acute and chronic oral GVHD and included mucosal lichenoid changes, erythema, ulcerations and pseudomembranes, satellite necrosis, apoptotic bodies and lichenoid interface inflammation. Conclusions: It is necessary to consider complex clinical symptomatology and pathological correlations when classifying the oral GVHD, because local oral symptoms and histopathological features in both acute and chronic oral GVHD forms can be similar. Even though the oral chronic GVHD was mild in the majority of patients, it can be considered as clinically significant due to its incidence, duration and symptomatology. The FLU/MEL conditioning regimen should not be considered as low-risk protocol in this context.
引用
收藏
页码:CR480 / CR484
页数:5
相关论文
共 50 条
  • [41] New ways to separate Graft-versus-Host Disease and Graft-versus-Tumour effects after allogeneic haematopoietic stem cell transplantation
    Kotsiou, Eleni
    Davies, Jeff K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (02) : 133 - 145
  • [42] Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation
    N Fujii
    K Takenaka
    K Shinagawa
    K Ikeda
    Y Maeda
    K Sunami
    Y Hiramatsu
    K Matsuo
    F Ishimaru
    K Niiya
    T Yoshino
    N Hirabayashi
    M Harada
    Bone Marrow Transplantation, 2001, 27 : 1007 - 1010
  • [43] Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Kaito, Yuta
    Yui, Shunsuke
    Inai, Kazuki
    Onai, Daishi
    Kinoshita, Ryosuke
    Yamanaka, Satoshi
    Okamoto, Muneo
    Wada, Ryuichi
    Ohashi, Ryuji
    Inokuchi, Koiti
    Yamaguchi, Hiroki
    INTERNAL MEDICINE, 2021, 60 (20) : 3299 - 3304
  • [44] Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation
    Yaman, Yontem
    Baysoy, Gokhan
    Kelesoglu, Emre
    Ozdilli, Kursat
    Cakir, Asli
    Genc, Dildar Bahar
    Elli, Murat
    Anak, Sema
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2019, 23 (01): : 59 - 62
  • [45] Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation
    Funke, Vaneuza A. M.
    Rodrigues Moreira, Maria Claudia
    Vigorito, Afonso Celso
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 : 44 - 50
  • [46] Lung transplantation for chronic graft-versus-host disease after hematopoietic stem cell transplantation
    Brugiere, O.
    Bergeron, A.
    Le Pavec, J.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 : E69 - E72
  • [47] Graft-versus-host disease after allogeneic stem cell transplantation: Evolving concepts and novel therapies including photopheresis
    Komanduri, KV
    Couriel, D
    Champlin, RE
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) : 1 - 6
  • [48] Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation
    Weissinger, E. M.
    Metzger, J.
    Dobbelstein, C.
    Wolff, D.
    Schleuning, M.
    Kuzmina, Z.
    Greinix, H.
    Dickinson, A. M.
    Mullen, W.
    Kreipe, H.
    Hamwi, I.
    Morgan, M.
    Krons, A.
    Tchebotarenko, I.
    Ihlenburg-Schwarz, D.
    Dammann, E.
    Collin, M.
    Ehrlich, S.
    Diedrich, H.
    Stadler, M.
    Eder, M.
    Holler, E.
    Mischak, H.
    Krauter, J.
    Ganser, A.
    LEUKEMIA, 2014, 28 (04) : 842 - 852
  • [49] Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Huang, XJ
    Jiang, Q
    Chen, H
    Xu, L
    Liu, D
    Chen, Y
    Han, W
    Zhang, Y
    Liu, K
    Lu, D
    BONE MARROW TRANSPLANTATION, 2005, 36 (04) : 343 - 348
  • [50] A case of tongue carcinoma associated with chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Noguchi, K.
    Nakase, M.
    Inui, M.
    Nakamura, S.
    Okumura, K.
    Tagawa, T.
    AUSTRALIAN DENTAL JOURNAL, 2010, 55 (02) : 200 - 202